Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
Eddy Pérez-Then, Carolina Lucas, Valter Silva Monteiro, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 481-485
Open Access | Times Cited: 379

Showing 1-25 of 379 citing articles:

COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review
Santenna Chenchula, Padmavathi Karunakaran, Sushil Sharma, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2969-2976
Open Access | Times Cited: 294
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Modeling transmission of SARS-CoV-2 Omicron in China
Jun Cai, Xiaowei Deng, Juan Yang, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1468-1475
Open Access | Times Cited: 251
COVID-19 mRNA vaccines: Platforms and current developments
Gábor Szabó, Azita J. Mahiny, Irena Vlatkovic
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1850-1868
Open Access | Times Cited: 194
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112443-112443
Open Access | Times Cited: 144
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 137
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022
Pak‐Hin Hinson Cheung, Chi‐Ping Chan, Dong‐Yan Jin
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1072-1078
Open Access | Times Cited: 130
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 585-595.e6
Open Access | Times Cited: 97
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Henning Gruell, Kanika Vanshylla, Michael Korenkov, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1231-1241.e6
Open Access | Times Cited: 71
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 69
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 46
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 42
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Jun Lan, Xinheng He, Yifei Ren, et al.
Cell Research (2022) Vol. 32, Iss. 6, pp. 593-595
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top